Oscar Health, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 150.03 million compared to USD 226.05 million a year ago. Basic loss per share from continuing operations was USD 0.66 compared to USD 1.05 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.64 USD | -2.43% | +20.09% | +136.50% |
05-09 | Goldman Sachs Adjusts Price Target on Oscar Health to $21 From $16, Maintains Neutral Rating | MT |
05-07 | Sector Update: Health Care Stocks Advance in Late Afternoon Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+136.50% | 5.13B | |
+26.90% | 10.79B | |
+2.53% | 6.64B | |
+19.97% | 6.25B | |
+0.95% | 2.39B | |
-15.44% | 1.08B | |
+135.42% | 949M | |
-0.42% | 839M | |
+6.42% | 160M | |
-6.17% | 70.96M |
- Stock Market
- Equities
- OSCR Stock
- News Oscar Health, Inc.
- Oscar Health, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023